Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Older IBD patients at disadvantage for medications, surgery
Older patients with inflammatory bowel disease (IBD) are less likely to be initiated on medications and are often scheduled for surgeries, a study has found.
Older IBD patients at disadvantage for medications, surgery
29 Apr 2023Clindamycin delivers in bacterial vaginosis
Use of a single dose of a new bioadhesive 2% clindamycin vaginal gel in the treatment of bacterial vaginosis appears to result in a rapid resolution of symptoms, with high acceptability among women, as reported in a study.
Clindamycin delivers in bacterial vaginosis
29 Apr 2023Tralokinumab a promising treatment option in young people with moderate-to-severe AD
Targeting interleukin (IL)-13 with tralokinumab monotherapy helps reduce disease activity in adolescents with moderate-to-severe atopic dermatitis (AD) with a low frequency of conjunctivitis throughout the treatment period, according to data from the phase III ECZTRA 6 trial.
Tralokinumab a promising treatment option in young people with moderate-to-severe AD
29 Apr 2023Laser acupuncture plus vitamins beneficial in postmenopausal women with osteoporosis
Laser acupuncture, when combined with supplementation with calcium and fluoride-containing vitamin D, appears to increase forearm bone mineral density and reduce wrist pain in postmenopausal women with osteoporosis, according to the results of a randomized controlled trial.
Laser acupuncture plus vitamins beneficial in postmenopausal women with osteoporosis
28 Apr 2023Immune-related AEs tied to improved survival in bladder cancer patients on atezolizumab
In patients with locally advanced or metastatic urothelial cancer patients receiving atezolizumab treatment, immune-related adverse events (AEs) were associated with improved survival outcomes, according to an analysis of individual participant data from the IMvigor210 and IMvigor211 studies.
Immune-related AEs tied to improved survival in bladder cancer patients on atezolizumab
27 Apr 2023Bivalent mRNA-1273.214 booster offers superior immunogenicity vs original vax
The bivalent mRNA-1273.214 booster vaccine provides superior immunogenicity compared with the original COVID-19 mRNA-1273 vaccine in a phase III study, according to an expert who presented at ECCMID 2023.